VTYX - Ventyx Biosciences Inc. (VTYX) Q1 2024 Earnings Call Transcript
2024-05-11 13:58:07 ET
Ventyx Biosciences, Inc. (VTYX)
Q1 2024 Earnings Conference Call
May 9, 2024 16:30 ET
Company Participants
Martin Auster - Chief Financial Officer
Raju Mohan - Founder and Chief Executive Officer
John Nuss - Chief Scientific Officer
Conference Call Participants
Liam Hiester - Piper Sandler
Emily Bodnar - H.C. Wainwright
Gospel Enyindah-Asonye - Morgan Stanley
Alex Thompson - Stifel
Derek Archila - Wells Fargo
Sam Slutsky - Life Science
Presentation
Operator
Good afternoon, ladies and gentlemen and welcome to the Ventyx Biosciences First Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the call over to Dr. Martin Auster, Ventyx’ Chief Financial Officer. Please begin.
Martin Auster
Thank you, operator, and good afternoon to everyone joining us today. Welcome to Ventyx Biosciences conference call webcast where we’ll be discussing our first quarter 2024 financial results and providing a corporate update.
Before we begin, I would like to remind everyone that today’s presentations will include forward-looking statements. These statements are subject to risks and uncertainties that may cause actual results to differ materially from those projected. A description of these risks can be found in our Form 10-Q for the quarter ended March 31, 2024, which was just recently filed this afternoon. Any forward-looking statements are made only as of today’s date, and we assume no obligation to update any forward-looking statements made on today’s call....
Ventyx Biosciences, Inc. (VTYX) Q1 2024 Earnings Call Transcript